CoChat

Hypoxia in cancer: significance and impact on clinical outcome

Vaupel, Peter, Mayer, Arnulf · 2007 · Cancer and Metastasis Reviews

The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.

Abstract

Hypoxia, a characteristic feature of locally advanced solid tumors, has emerged as a pivotal factor of the tumor (patho-)physiome since it can promote tumor progression and resistance to therapy. Hypoxia represents a "Janus face" in tumor biology because (a) it is associated with restrained proliferation, differentiation, necrosis or apoptosis, and (b) it can also lead to the development of an aggressive phenotype. Independent of standard prognostic factors, such as tumor stage and nodal status, hypoxia has been suggested as an adverse prognostic factor for patient outcome. Studies of tumor hypoxia involving the direct assessment of the oxygenation status have suggested worse disease-free survival for patients with hypoxic cervical cancers or soft tissue sarcomas. In head & neck cancers the studies suggest that hypoxia is prognostic for survival and local control. Technical limitations of the direct O(2) sensing technique have prompted the use of surrogate markers for tumor hypoxia, such as hypoxia-related endogenous proteins (e.g., HIF-1alpha, GLUT-1, CA IX) or exogenous bioreductive drugs. In many - albeit not in all - studies endogenous markers showed prognostic significance for patient outcome. The prognostic relevance of exogenous markers, however, appears to be limited. Noninvasive assessment of hypoxia using imaging techniques can be achieved with PET or SPECT detection of radiolabeled tracers or with MRI techniques (e.g., BOLD). Clinical experience with these methods regarding patient prognosis is so far only limited. In the clinical studies performed up until now, the lack of standardized treatment protocols, inconsistencies of the endpoints characterizing the oxygenation status and methodological differences (e.g., different immunohistochemical staining procedures) may compromise the power of the prognostic parameter used.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10555-007-9055-1

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 145 references

Research works printed but not linked: 2

  1. Vaupel, P., & Kelleher, D. K. (1999). Tumor hypoxia. Stuttgart: Wissenschaftliche Verlagsgesellschaft.
  2. Brizel, D. M. (1999). Human tumor oxygenation: The Duke University Medical Center experience. In P. Vaupel & D. K. Kelleher (Eds.), Tumor hypoxia (pp. 29–38). Stuttgart: Wissenschaftliche Verlagsgesellschaft.

Cited by

See all 2,240

Metadata

Authors
Vaupel, P., & Mayer, A.
Affiliations
Johannes Gutenberg University Mainz (DE)
Corresponding author
Vaupel, Peter
Venue
Cancer and Metastasis Reviews
Published
2007-04-18
Volume
26
Issue
2
Pages
225-239
ISSN
  • 0167-7659 (ISSN-L)
  • 1573-7233
OpenAlex
W2124496728
Cited by
2,240
References
145
Citations by year
2026: 103 · 2025: 83 · 2024: 92 · 2023: 125 · 2022: 144 · 2021: 157 · 2020: 157 · 2019: 145 · 2018: 146 · 2017: 145 · 2016: 150 · 2015: 132 · 2014: 128 · 2013: 126 · 2012: 108
FWCI
5.75
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Cancer and Metastasis Reviews (publishedVersion)
  • PubMed (publishedVersion)
Funders
Deutsche Krebshilfe
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
tumor hypoxia, prognostic factors, clinical outcomes, solid tumors, HIF-1α, GLUT1, CAIX, bioreductive drugs, oxygenation status, head and neck cancer, cervical cancer, soft tissue sarcoma, BOLD MRI, tumor progression, treatment resistance
MeSH terms
Uterine Cervical Neoplasms, Female, Humans, Neoplasms, Prognosis, Cell Hypoxia, Treatment Outcome, Drug Resistance, Neoplasm

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypoxia in cancer: significance and impact on clinical outcome. https://app.cochat.ai/papers/10.1007/s10555-007-9055-1
The paper
Vaupel, P., & Mayer, A. (2007). Hypoxia in cancer: significance and impact on clinical outcome. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-007-9055-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.